JOHN SWING: Open Payments
NPI 1366493686 · FREDERICKSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,388 in 58 payments from 11 companies in 2025. Trend: 2023 $15,806 · 2024 $5,429 · 2025 $1,388
Food & beverage: $1,361Education: $27
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 12 | $363 |
| E.R. Squibb & Sons, L.L.C. | 6 | $222 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $190 |
| Vanda Pharmaceuticals Inc. | 5 | $154 |
| Alkermes, Inc. | 4 | $106 |
| Teva Pharmaceuticals USA, Inc. | 4 | $101 |
| Otsuka America Pharmaceutical, Inc. | 4 | $86 |
| Janssen Pharmaceuticals, Inc | 2 | $77 |
| Axsome Therapeutics, Inc. | 3 | $48 |
| Lundbeck LLC | 1 | $23 |
Products named: INGREZZA, COBENFY, CAPLYTA, ARISTADA, UZEDY, ABILIFY ASIMTUFII, HETLIOZ, INVEGA SUSTENNA.
Industry payments across VA — which companies pay providers there.
